|
2026 Journal Article Hospital-Admitted Injection-Related Infections Among Incarcerated People Who Inject Drugs in Australia: A Retrospective Cohort StudyPalmer, Andrew, Carter, Matthew, Yeo, Jeremy, Shim, Cecilia, Connor, Jason, Hayllar, Jeremy, Holtmann, Gerald, Moy, Naomi, Playford, Elliott G., Runnegar, Naomi and Clark, Paul J. (2026). Hospital-Admitted Injection-Related Infections Among Incarcerated People Who Inject Drugs in Australia: A Retrospective Cohort Study. Medical Journal of Australia, 224 (6) e70224. doi: 10.5694/mja2.70224 |
|
2026 Journal Article ROLE OF ANXIETY AND DEPRESSION ON THE INTERPLAY BETWEEN DISORDERS OF GUT-BRAIN INTERACTION AND EATING DISORDERSEgboh, SC, Koloski, NA, Jones, MP, Shah, A, Holtmann, G and Talley, NJ (2026). ROLE OF ANXIETY AND DEPRESSION ON THE INTERPLAY BETWEEN DISORDERS OF GUT-BRAIN INTERACTION AND EATING DISORDERS. Clinical and Translational Gastroenterology, Publish Ahead of Print 10.14309/ctg.0000000000001025. doi: 10.14309/ctg.0000000000001025 |
|
2026 Journal Article Sa1759 DISORDERS OF GUT-BRAIN INTERACTION PRESENTING WITH SEVERELY ALTERED FOOD INTAKE BEHAVIOR (DGBI-AFIB): CHARACTERISATION OF A DISTINCT PATIENT GROUPShah, Ayesha, Moy, Naomi, Kulin, Dmitrii, Callaghan, Gavin, Fairlie, Thomas, Virgo, Kate, Hansen, Teressa J., Jones, Michael P., Koloski, Natasha A., Thapar, Nikhil and Holtmann, Gerald (2026). Sa1759 DISORDERS OF GUT-BRAIN INTERACTION PRESENTING WITH SEVERELY ALTERED FOOD INTAKE BEHAVIOR (DGBI-AFIB): CHARACTERISATION OF A DISTINCT PATIENT GROUP. Gastroenterology, 170 (6), S-1850. doi: 10.1016/s0016-5085(26)04460-4 |
|
2026 Journal Article Tu1102 SINGLE ADMINISTRATION OF EP-104GI IN RESOLVE, A PHASE 1B/2 TRIAL IN EOSINOPHILIC ESOPHAGITIS, IMPROVES ENDOSCOPIC FEATURES OF INFLAMMATION AND FIBROSIS OVER 36 WEEKSGonsalves, Nirmala, Nguyen, Nam Q., Ko, Hin Hin, Ho, Vincent, Afif, Waqqas, Holtmann, Gerald J., Dellon, Evan S., Ravikumar, Pranali, Dye, Andrew, Malone, Amanda and Kowalski, Mark M. (2026). Tu1102 SINGLE ADMINISTRATION OF EP-104GI IN RESOLVE, A PHASE 1B/2 TRIAL IN EOSINOPHILIC ESOPHAGITIS, IMPROVES ENDOSCOPIC FEATURES OF INFLAMMATION AND FIBROSIS OVER 36 WEEKS. Gastroenterology, 170 (6), S-817. doi: 10.1016/s0016-5085(26)02202-x |
|
2026 Journal Article Tu1669 CHRONIC GASTROINTESTINAL SYMPTOMS AND SYSTEMIC COMORBIDITIES IN ADULT PATIENTS WITH HYPERMOBILITY SPECTRUM DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSISKulin, Dmitrii, Shah, Ayesha, Fairlie, Thomas, Staller, Kyle, Nurko, Samuel, Keefer, Laurie, Aziz, Qasim, Drossman, Douglas A., Jones, Michael P. and Holtmann, Gerald (2026). Tu1669 CHRONIC GASTROINTESTINAL SYMPTOMS AND SYSTEMIC COMORBIDITIES IN ADULT PATIENTS WITH HYPERMOBILITY SPECTRUM DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology, 170 (6), S-1946. doi: 10.1016/s0016-5085(26)04668-8 |
|
2026 Journal Article Sociocultural aspects of the pathophysiology, clinical presentation and management of disorders of gut-brain interactionWong, Reuben K., Fang, Xiucai, Ghoshal, Uday C., Kashyap, Purna C., Mulak, Agata, Lee, Yeong Yeh, Sperber, Ami D. and Holtmann, Gerald (2026). Sociocultural aspects of the pathophysiology, clinical presentation and management of disorders of gut-brain interaction. Gastroenterology, 170 (6), 1190-1204. doi: 10.1053/j.gastro.2026.02.006 |
|
2026 Journal Article Tu1700 PREVALENCE OF ORTHOSTATIC INTOLERANCE IN PATIENTS WITH DISORDERS OF GUT-BRAIN INTERACTION: A SYSTEMATIC REVIEW AND META-ANALYSISAyaki, Kana, Shah, Ayesha, Fairlie, Thomas, Kulin, Dmitrii, Staller, Kyle, Nurko, Samuel, Keefer, Laurie, Aziz, Qasim, Drossman, Douglas A., Jones, Michael P. and Holtmann, Gerald (2026). Tu1700 PREVALENCE OF ORTHOSTATIC INTOLERANCE IN PATIENTS WITH DISORDERS OF GUT-BRAIN INTERACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastrointestinal Endoscopy, 103 (5), S-1961. doi: 10.1016/s0016-5107(26)04630-4 |
|
2026 Journal Article 582 COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBIShah, Ayesha, Ghoshal, Uday C., Fairlie, Thomas, Ghoshal, Ujjala, Koloski, Natasha, Lim, Yenkai, Morrison, Mark, Sahu, Shikha, Singh, Madhuri, Spencer, Sean, Gibson, Peter R. and Holtmann, Gerald (2026). 582 COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBI. Gastrointestinal Endoscopy, 103 (5), S-2414. doi: 10.1016/s0016-5107(26)05633-6 |
|
2026 Journal Article Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTIONFairlie, Thomas, Celine, Patricia, Shah, Ayesha, Lim, Yenkai, Morrison, Mark and Holtmann, Gerald (2026). Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTION. Gastrointestinal Endoscopy, 103 (5), S-2457. doi: 10.1016/s0016-5107(26)05745-7 |
|
2026 Journal Article Su1114 ACUTE EFFECTS OF BOTULINUM TOXIN ON THE DISTENSIBILITY OF THE LES IN PATIENTS WTIH SUSPECTED ACHALASIA AND ESOPHAGEAL OUTLET OBSTRUCTIONLuong, Suzanna, Wang, William J., McKillen, Ben, Moy, Naomi, Do, Anh and Holtmann, Gerald (2026). Su1114 ACUTE EFFECTS OF BOTULINUM TOXIN ON THE DISTENSIBILITY OF THE LES IN PATIENTS WTIH SUSPECTED ACHALASIA AND ESOPHAGEAL OUTLET OBSTRUCTION. Gastroenterology, 170 (6), S-723. doi: 10.1016/s0016-5085(26)01999-2 |
|
2026 Journal Article Sa1759 DISORDERS OF GUT-BRAIN INTERACTION PRESENTING WITH SEVERELY ALTERED FOOD INTAKE BEHAVIOR (DGBI-AFIB): CHARACTERISATION OF A DISTINCT PATIENT GROUPShah, Ayesha, Moy, Naomi, Kulin, Dmitrii, Callaghan, Gavin, Fairlie, Thomas, Virgo, Kate, Hansen, Teressa J., Jones, Michael P., Koloski, Natasha A., Thapar, Nikhil and Holtmann, Gerald (2026). Sa1759 DISORDERS OF GUT-BRAIN INTERACTION PRESENTING WITH SEVERELY ALTERED FOOD INTAKE BEHAVIOR (DGBI-AFIB): CHARACTERISATION OF A DISTINCT PATIENT GROUP. Gastrointestinal Endoscopy, 103 (5), S-1850. doi: 10.1016/s0016-5107(26)04391-9 |
|
2026 Journal Article Tu1101 DURABILITY OF DYSPHAGIA IMPROVEMENTS FOLLOWING SINGLE ADMINISTRATION OF EP-104GI IN PARTICIPANTS WITH EOSINOPHILIC ESOPHAGITIS DURING DOSE ESCALATION IN THE RESOLVE TRIALBredenoord, Albert J., Nguyen, Nam Q., Ho, Vincent, Ko, Hin Hin, Afif, Waqqas, Holtmann, Gerald J., Dellon, Evan S., Kolisnik, Tyler, Dye, Andrew, Malone, Amanda and Kowalski, Mark M. (2026). Tu1101 DURABILITY OF DYSPHAGIA IMPROVEMENTS FOLLOWING SINGLE ADMINISTRATION OF EP-104GI IN PARTICIPANTS WITH EOSINOPHILIC ESOPHAGITIS DURING DOSE ESCALATION IN THE RESOLVE TRIAL. Gastroenterology, 170 (6), S-817. doi: 10.1016/s0016-5085(26)02201-8 |
|
2026 Journal Article Tu1669 CHRONIC GASTROINTESTINAL SYMPTOMS AND SYSTEMIC COMORBIDITIES IN ADULT PATIENTS WITH HYPERMOBILITY SPECTRUM DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSISKulin, Dmitrii, Shah, Ayesha, Fairlie, Thomas, Staller, Kyle, Nurko, Samuel, Keefer, Laurie, Aziz, Qasim, Drossman, Douglas A., Jones, Michael P. and Holtmann, Gerald (2026). Tu1669 CHRONIC GASTROINTESTINAL SYMPTOMS AND SYSTEMIC COMORBIDITIES IN ADULT PATIENTS WITH HYPERMOBILITY SPECTRUM DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastrointestinal Endoscopy, 103 (5), S-1946. doi: 10.1016/s0016-5107(26)04599-2 |
|
2026 Journal Article Su1114 ACUTE EFFECTS OF BOTULINUM TOXIN ON THE DISTENSIBILITY OF THE LES IN PATIENTS WTIH SUSPECTED ACHALASIA AND ESOPHAGEAL OUTLET OBSTRUCTIONLuong, Suzanna, Wang, William J., McKillen, Ben, Moy, Naomi, Do, Anh and Holtmann, Gerald (2026). Su1114 ACUTE EFFECTS OF BOTULINUM TOXIN ON THE DISTENSIBILITY OF THE LES IN PATIENTS WTIH SUSPECTED ACHALASIA AND ESOPHAGEAL OUTLET OBSTRUCTION. Gastrointestinal Endoscopy, 103 (5), S-723. doi: 10.1016/s0016-5107(26)01930-9 |
|
2026 Journal Article Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTIONFairlie, Thomas, Celine, Patricia, Shah, Ayesha, Lim, Yenkai, Morrison, Mark and Holtmann, Gerald (2026). Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTION. Gastroenterology, 170 (6), S-2457. doi: 10.1016/s0016-5085(26)05814-2 |
|
2026 Journal Article Critical Review: The Past, Present, and Future of Small Intestinal Bacterial Overgrowth ( <scp>SIBO</scp> )Shah, Ayesha, Holtmann, Gerald and Gibson, Peter R. (2026). Critical Review: The Past, Present, and Future of Small Intestinal Bacterial Overgrowth ( SIBO ). JGH Open, 10 (5) e70419. doi: 10.1002/jgh3.70419 |
|
2026 Journal Article Sa1003 TRUST OF PATIENTS AND CONSUMERS IN AI-SUPPORTED CLINICAL DECISION MAKING: RESULTS FROM AN AI-SUPPORTED SYSTEMATIC REVIEWWilmes, Sophie, Holtmann, Gerald, Shah, Ayesha and Moy, Naomi (2026). Sa1003 TRUST OF PATIENTS AND CONSUMERS IN AI-SUPPORTED CLINICAL DECISION MAKING: RESULTS FROM AN AI-SUPPORTED SYSTEMATIC REVIEW. Gastrointestinal Endoscopy, 103 (5), S-2343. doi: 10.1016/s0016-5107(26)05474-x |
|
2026 Journal Article Sa1003 TRUST OF PATIENTS AND CONSUMERS IN AI-SUPPORTED CLINICAL DECISION MAKING: RESULTS FROM AN AI-SUPPORTED SYSTEMATIC REVIEWWilmes, Sophie, Holtmann, Gerald, Shah, Ayesha and Moy, Naomi (2026). Sa1003 TRUST OF PATIENTS AND CONSUMERS IN AI-SUPPORTED CLINICAL DECISION MAKING: RESULTS FROM AN AI-SUPPORTED SYSTEMATIC REVIEW. Gastroenterology, 170 (6), S-2343. doi: 10.1016/s0016-5085(26)05543-5 |
|
2026 Journal Article Tu1102 SINGLE ADMINISTRATION OF EP-104GI IN RESOLVE, A PHASE 1B/2 TRIAL IN EOSINOPHILIC ESOPHAGITIS, IMPROVES ENDOSCOPIC FEATURES OF INFLAMMATION AND FIBROSIS OVER 36 WEEKSGonsalves, Nirmala, Nguyen, Nam Q., Ko, Hin Hin, Ho, Vincent, Afif, Waqqas, Holtmann, Gerald J., Dellon, Evan S., Ravikumar, Pranali, Dye, Andrew, Malone, Amanda and Kowalski, Mark M. (2026). Tu1102 SINGLE ADMINISTRATION OF EP-104GI IN RESOLVE, A PHASE 1B/2 TRIAL IN EOSINOPHILIC ESOPHAGITIS, IMPROVES ENDOSCOPIC FEATURES OF INFLAMMATION AND FIBROSIS OVER 36 WEEKS. Gastrointestinal Endoscopy, 103 (5), S-817. doi: 10.1016/s0016-5107(26)02133-4 |
|
2026 Journal Article 400 SINGLE ADMINISTRATION OF ESCALATING DOSES OF EP-104GI LEADS TO PERSISTENT IMPROVEMENTS IN HISTOLOGICAL FEATURES OF EOSINOPHILIC ESOPHAGITIS OVER 36 WEEKS IN RESOLVE, A PHASE 1B/2 DOSE ESCALATION AND OPTIMIZATION TRIALMa, Christopher, Nguyen, Nam Q., Ko, Hin Hin, Ho, Vincent, Afif, Waqqas, Holtmann, Gerald J., Dellon, Evan S., Dobek, Christine, Dye, Andrew, Kowalski, Mark M. and Malone, Amanda (2026). 400 SINGLE ADMINISTRATION OF ESCALATING DOSES OF EP-104GI LEADS TO PERSISTENT IMPROVEMENTS IN HISTOLOGICAL FEATURES OF EOSINOPHILIC ESOPHAGITIS OVER 36 WEEKS IN RESOLVE, A PHASE 1B/2 DOSE ESCALATION AND OPTIMIZATION TRIAL. Gastroenterology, 170 (6), S-627. doi: 10.1016/s0016-5085(26)01797-x |
